|
DLST expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.727200E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.184000E-01 |
| Normal-vs-Stage2 |
1.255540E-02 |
| Normal-vs-Stage3 |
2.992400E-02 |
| Normal-vs-Stage4 |
5.373700E-02 |
| Stage1-vs-Stage2 |
1.084010E-03 |
| Stage1-vs-Stage3 |
1.634630E-01 |
| Stage1-vs-Stage4 |
2.697000E-01 |
| Stage2-vs-Stage3 |
1.764000E-04 |
| Stage2-vs-Stage4 |
3.248400E-04 |
| Stage3-vs-Stage4 |
9.778200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.029600E-01 |
| Normal-vs-AfricanAmerican |
3.418600E-01 |
| Normal-vs-Asian |
6.701800E-01 |
| Caucasian-vs-AfricanAmerican |
8.747600E-01 |
| Caucasian-vs-Asian |
6.737800E-01 |
| AfricanAmerican-vs-Asian |
6.864400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.188580E-01 |
| Normal-vs-Female |
4.426000E-01 |
| Male-vs-Female |
2.554800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.094600E-01 |
| Normal-vs-Age(41-60Yrs) |
2.441200E-01 |
| Normal-vs-Age(61-80Yrs) |
6.303800E-01 |
| Normal-vs-Age(81-100Yrs) |
1.734430E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.599000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.387400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.818000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.841000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.316000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.277800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.174370E-01 |
| Classical-VS-Follicular |
2.095000E-01 |
| Classical-VS-Other |
1.398030E-01 |
| Classical-VS-Normal |
3.811800E-01 |
| Tall-VS-Follicular |
2.164300E-02 |
| Tall-VS-Other |
4.930200E-01 |
| Tall-VS-Normal |
2.981600E-02 |
| Follicular-VS-Other |
1.313840E-01 |
| Follicular-VS-Normal |
6.357600E-01 |
| Other-VS-Normal |
3.941800E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.945400E-01 |
| Normal-vs-N1 |
8.812000E-04 |
| N0-vs-N1 |
2.380300E-03 |
|
|
